Latest Insider Transactions at Senseonics Holdings, Inc. (SENS)
This section provides a real-time view of insider transactions for Senseonics Holdings, Inc. (SENS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Senseonics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Senseonics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Douglas A Roeder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.74%
|
$0
$0.5 P/Share
|
|
Dec 12
2024
|
Douglas A Roeder |
BUY
Open market or private purchase
|
Direct |
300,000
+17.77%
|
$0
$0.41 P/Share
|
|
Dec 12
2024
|
Frederick T. Sullivan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
124,933
+4.8%
|
$0
$0.38 P/Share
|
|
Dec 10
2024
|
Timothy T Goodnow President and CEO |
BUY
Open market or private purchase
|
Direct |
315,000
+2.71%
|
$0
$0.31 P/Share
|
|
Nov 15
2024
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
632,166
-5.44%
|
$0
$0.28 P/Share
|
|
Nov 15
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
187,665
-6.48%
|
$0
$0.28 P/Share
|
|
Nov 15
2024
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
282,546
-5.63%
|
$0
$0.28 P/Share
|
|
Nov 15
2024
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
118,645
-5.02%
|
$0
$0.28 P/Share
|
|
Nov 15
2024
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
181,627
-7.16%
|
$0
$0.28 P/Share
|
|
Oct 01
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
41,901
+3.51%
|
$0
$0.34 P/Share
|
|
Oct 01
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
38,193
+3.42%
|
$0
$0.34 P/Share
|
|
Oct 01
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
24,102
+2.53%
|
$0
$0.34 P/Share
|
|
Oct 01
2024
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
43,755
+3.87%
|
$0
$0.34 P/Share
|
|
Jul 01
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
32,529
+3.03%
|
$0
$0.4 P/Share
|
|
Jul 01
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
35,687
+3.11%
|
$0
$0.4 P/Share
|
|
Jul 01
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
20,528
+2.22%
|
$0
$0.4 P/Share
|
|
Jun 15
2024
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
275,206
-2.31%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
79,242
-3.03%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
80,785
-2.72%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
132,448
-2.57%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
64,722
-2.66%
|
$0
$0.39 P/Share
|
|
May 23
2024
|
Timothy T Goodnow President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,553,551
+27.67%
|
-
|
|
May 23
2024
|
Frederick T. Sullivan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,336,005
+33.82%
|
-
|
|
May 23
2024
|
Mukul Jain Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,204,408
+29.98%
|
-
|
|
May 23
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
1,135,604
+27.63%
|
-
|
|
May 23
2024
|
Francine Kaufman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,024,270
+29.66%
|
-
|
|
May 22
2024
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+18.45%
|
-
|
|
May 22
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+18.02%
|
-
|
|
May 22
2024
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+11.0%
|
-
|
|
May 22
2024
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+30.89%
|
-
|
|
May 22
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+21.07%
|
-
|
|
May 22
2024
|
Anthony R. Raab |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+25.22%
|
-
|
|
May 22
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+19.0%
|
-
|
|
May 15
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
108,100
-5.55%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
151,796
-4.9%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
53,923
-3.7%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
359,114
-4.66%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102,386
-7.41%
|
$0
$0.5 P/Share
|
|
Apr 02
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
25,245
+3.17%
|
$0
$0.51 P/Share
|
|
Apr 02
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
27,696
+3.2%
|
$0
$0.51 P/Share
|
|
Apr 02
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
15,931
+2.4%
|
$0
$0.51 P/Share
|
|
Jan 02
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
14,508
+2.24%
|
$0
$0.56 P/Share
|
|
Jan 02
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
22,991
+2.99%
|
$0
$0.56 P/Share
|
|
Jan 02
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
25,223
+3.02%
|
$0
$0.56 P/Share
|
|
Jan 02
2024
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
42,410
+2.47%
|
$0
$0.56 P/Share
|
|
Nov 15
2023
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
163,319
-7.74%
|
$0
$0.61 P/Share
|
|
Nov 15
2023
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
266,908
-7.94%
|
$0
$0.61 P/Share
|
|
Nov 15
2023
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115,908
-7.36%
|
$0
$0.61 P/Share
|
|
Nov 15
2023
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
591,945
-7.13%
|
$0
$0.61 P/Share
|
|
Nov 15
2023
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102,383
-6.9%
|
$0
$0.61 P/Share
|